Details for 2020165284
Up to date per 04.04.2026
Actions
Details for 2020165284
Granted/Registered
European Patent
28.10.2020 A
04.05.2022 B1
06.06.2012
US
201261656451 P
A61K 31/137 20060101AFI20210923BHEP
Owner
Nalpropion Pharmaceuticals LLC155 Franklin Rd, Suite 450 Brentwood, TN 37027US
Representative
Representative
Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT
Inventor
KLASSEN, Preston7762 Lookout Drive La Jolla, CA 92037US
TAYLOR, Kristin15023 Palomino Mesa Road San Diego, CA 92127US
Information about Fees